A multi-channel microfluidic platform based on human flavin-containing monooxygenase 3 for personalised medicine.
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
22 Apr 2024
22 Apr 2024
Historique:
received:
27
02
2024
accepted:
16
04
2024
medline:
24
4
2024
pubmed:
24
4
2024
entrez:
24
4
2024
Statut:
epublish
Résumé
Human flavin-containing monooxygenase 3 (FMO3) is a drug-metabolizing enzyme (DME) which is known to be highly polymorphic. Some of its polymorphic variants are associated with inter-individual differences that contribute to drug response. In order to measure these differences, the implementation of a quick and efficient
Identifiants
pubmed: 38655484
doi: 10.1039/d4ra01516a
pii: d4ra01516a
pmc: PMC11037025
doi:
Types de publication
Journal Article
Langues
eng
Pagination
13209-13217Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts to declare.
Références
Toxicol Appl Pharmacol. 2003 Jun 15;189(3):233-46
pubmed: 12791308
Curr Drug Metab. 2012 Feb;13(2):215-24
pubmed: 22300020
Biotechnol Adv. 2021 Nov 15;52:107821
pubmed: 34455028
Anal Chem. 2015 Mar 3;87(5):2974-80
pubmed: 25630629
Biochim Biophys Acta. 2016 Sep;1864(9):1177-1187
pubmed: 27344049
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Basic Clin Pharmacol Toxicol. 2018 Dec;123(6):687-691
pubmed: 29959872
Chem Rev. 2021 Jul 14;121(13):7468-7529
pubmed: 34024093
Int J Mol Sci. 2020 Oct 31;21(21):
pubmed: 33142951
Biochem Pharmacol. 2012 Feb 15;83(4):551-8
pubmed: 22177984
Biotechnol Adv. 2012 May-Jun;30(3):512-23
pubmed: 21963605
Clin Chem Lab Med. 2003 Apr;41(4):573-80
pubmed: 12747605
Drug Metab Rev. 2006;38(1-2):139-47
pubmed: 16684653
Anal Chem. 2021 Jan 12;93(1):311-331
pubmed: 33170661
Pharmacol Ther. 2005 Jun;106(3):357-87
pubmed: 15922018
Biochem Pharmacol. 2018 Dec;158:134-140
pubmed: 30308189
Talanta. 2017 May 1;166:275-283
pubmed: 28213235
Lab Chip. 2017 Nov 21;17(23):3960-3978
pubmed: 28913530
Drug Metab Rev. 2002 Aug;34(3):503-11
pubmed: 12214662
Microb Biotechnol. 2012 Nov;5(6):700-16
pubmed: 22862894
Analyst. 2011 Dec 21;136(24):5190-6
pubmed: 22013584
J Biochem Biophys Methods. 2006 Jun 30;67(2-3):107-22
pubmed: 16516301
Nat Rev Drug Discov. 2019 Jul;18(7):495-496
pubmed: 31267067
Clin Hemorheol Microcirc. 2015;61(3):523-39
pubmed: 26444589
Arch Biochem Biophys. 2021 Jan 15;697:108663
pubmed: 33152328
Annu Rev Pharmacol Toxicol. 2006;46:65-100
pubmed: 16402899
J Biochem Mol Toxicol. 2000;14(2):118-20
pubmed: 10630426
Xenobiotica. 2020 Jan;50(1):19-33
pubmed: 31317802
Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):379-93
pubmed: 24392841
Trends Pharmacol Sci. 2008 Jun;29(6):294-301
pubmed: 18423897
Biotechnol Adv. 2012 May-Jun;30(3):489-511
pubmed: 21951558